These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 34584131)

  • 1. Effects of Aβ-derived peptide fragments on fibrillogenesis of Aβ.
    Abedin F; Kandel N; Tatulian SA
    Sci Rep; 2021 Sep; 11(1):19262. PubMed ID: 34584131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues.
    Gordon DJ; Sciarretta KL; Meredith SC
    Biochemistry; 2001 Jul; 40(28):8237-45. PubMed ID: 11444969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif.
    Kino R; Araya T; Arai T; Sohma Y; Kanai M
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2972-5. PubMed ID: 26045033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity.
    Dai X; Hou W; Sun Y; Gao Z; Zhu S; Jiang Z
    Int J Mol Sci; 2015 May; 16(5):10526-36. PubMed ID: 26006224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.
    Zhang W; Du Y; Bai M; Xi Y; Li Z; Miao J
    J Pept Sci; 2013 Mar; 19(3):159-65. PubMed ID: 23349038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abeta20-29 peptide blocking apoE/Abeta interaction reduces full-length Abeta42/40 fibril formation and cytotoxicity in vitro.
    Hao J; Zhang W; Zhang P; Liu R; Liu L; Lei G; Su C; Miao J; Li Z
    Neuropeptides; 2010 Aug; 44(4):305-13. PubMed ID: 20363024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of a highly soluble Aβ
    LeVatte MA; Lipfert M; Ladner-Keay C; Wishart DS
    Protein Expr Purif; 2019 Dec; 164():105480. PubMed ID: 31425755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
    Sharma S; Nehru B; Saini A
    Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel antagonistic role of natural compound icariin on neurotoxicity of amyloid β peptide.
    Liu J; Liu Z; Zhang Y; Yin F
    Indian J Med Res; 2015 Aug; 142(2):190-5. PubMed ID: 26354216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationally designed peptidomimetic modulators of aβ toxicity in Alzheimer's disease.
    Rajasekhar K; Suresh SN; Manjithaya R; Govindaraju T
    Sci Rep; 2015 Jan; 5():8139. PubMed ID: 25633824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crocus-derived compounds alter the aggregation pathway of Alzheimer's Disease: associated beta amyloid protein.
    Koulakiotis NS; Purhonen P; Gikas E; Hebert H; Tsarbopoulos A
    Sci Rep; 2020 Oct; 10(1):18150. PubMed ID: 33097779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electric Field Disruption of Amyloid Aggregation: Potential Noninvasive Therapy for Alzheimer's Disease.
    Saikia J; Pandey G; Sasidharan S; Antony F; Nemade HB; Kumar S; Chaudhary N; Ramakrishnan V
    ACS Chem Neurosci; 2019 May; 10(5):2250-2262. PubMed ID: 30707008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyroglutamylated amyloid-β peptide reverses cross β-sheets by a prion-like mechanism.
    Matos JO; Goldblatt G; Jeon J; Chen B; Tatulian SA
    J Phys Chem B; 2014 May; 118(21):5637-43. PubMed ID: 24802697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential inhibitory effect of β-casein on the aggregation and deposition of Aβ
    Hojati S; Ghahghaei A; Lagzian M
    J Biomol Struct Dyn; 2018 Jun; 36(8):2118-2130. PubMed ID: 28633568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of d-Peptides for Aβ Monomer Binding Specificity Enhances Their Potential to Eliminate Toxic Aβ Oligomers.
    Klein AN; Ziehm T; van Groen T; Kadish I; Elfgen A; Tusche M; Thomaier M; Reiss K; Brener O; Gremer L; Kutzsche J; Willbold D
    ACS Chem Neurosci; 2017 Sep; 8(9):1889-1900. PubMed ID: 28581708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Aβ (1-40, 1-28, 11-22, and 29-40) aggregation processes and inhibition of toxic species generated in early stages of aggregation by a water-soluble ruthenium complex.
    Cali MP; Pereira LMB; Teodoro MD; Sellani TA; Rodrigues EG; Carlos RM
    J Inorg Biochem; 2021 Feb; 215():111314. PubMed ID: 33261934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferrocene tripeptide Gly-Pro-Arg conjugates: synthesis and inhibitory effects on Alzheimer's Aβ(1-42) fibrillogenesis and Aβ-induced cytotoxicity in vitro.
    Zhou B; Li CL; Hao YQ; Johnny MC; Liu YN; Li J
    Bioorg Med Chem; 2013 Jan; 21(2):395-402. PubMed ID: 23245572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of prion protein-derived peptides of potential use in Alzheimer's disease therapy.
    Nieznanska H; Bandyszewska M; Surewicz K; Zajkowski T; Surewicz WK; Nieznanski K
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2143-2153. PubMed ID: 29604335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of amyloid-β aggregation in Alzheimer's disease.
    Wang Q; Yu X; Li L; Zheng J
    Curr Pharm Des; 2014; 20(8):1223-43. PubMed ID: 23713775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Destabilization of β-amyloid aggregates by thrombin derived peptide: plausible role of thrombin in neuroprotection.
    De D; Bhattacharjee P; Das H; Kumar KS; Biswas SC; Bhattacharyya D
    FEBS J; 2020 Jun; 287(11):2386-2413. PubMed ID: 31747135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.